
Chengdu huasun technology group Inc., Ltd — Investor Relations & Filings
Chengdu Huasun Technology Group Inc., Ltd. specializes in the research, development, and production of pharmaceutical and biotechnological products. The company focuses on modernizing Traditional Chinese Medicine (TCM) alongside the development of chemical drugs and biological agents. Its primary product offerings target cardiovascular and cerebrovascular health, with a significant emphasis on proprietary formulations like the Sanchi Tongshu Capsule. The group integrates scientific research, manufacturing, and marketing operations to provide comprehensive healthcare solutions. Additionally, the company maintains interests in high-tech engineering and specialized building materials. By leveraging advanced R&D capabilities, the organization aims to bridge traditional therapeutic practices with modern medical standards to address complex health challenges.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于累计诉讼、仲裁情况的公告 | 2026-05-14 | Chinese | |
| 四川华信(集团)会计师事务所(特殊普通合伙)关于成都华神科技集团股份有限公司主板向特定对象发行股票的审计报告及财务报告 | 2026-05-06 | Chinese | |
| 关于向特定对象发行股票申请获得深圳证券交易所受理的公告 | 2026-05-06 | Chinese | |
| 第十三届董事会第三十次会议决议公告 | 2026-04-29 | Chinese | |
| 2026年一季度报告 | 2026-04-29 | Chinese | |
| 2025年年度股东会决议公告 | 2026-04-28 | Chinese |
Browse filings by year
27 years- 2026 62 filings
- 2025 117 filings
- 2024 97 filings
- 2023 172 filings
- 2022 114 filings
- 2021 167 filings
- 2020 92 filings
- 2019 59 filings
- 2018 68 filings
- 2017 134 filings
- 2016 123 filings
- 2015 112 filings
- 2014 78 filings
- 2013 80 filings
- 2012 81 filings
- 2011 71 filings
- 2010 61 filings
- 2009 54 filings
- 2008 49 filings
- 2007 45 filings
- 2006 41 filings
- 2005 26 filings
- 2004 30 filings
- 2003 20 filings
- 2002 19 filings
- 2001 9 filings
- 1998 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46344054 | 关于累计诉讼、仲裁情况的公告 | 2026-05-14 | Chinese | ||
| 44279237 | 四川华信(集团)会计师事务所(特殊普通合伙)关于成都华神科技集团股份有限公司主板向特定对象发行股票的审计报告及财务报告 | 2026-05-06 | Chinese | ||
| 43717481 | 关于向特定对象发行股票申请获得深圳证券交易所受理的公告 | 2026-05-06 | Chinese | ||
| 43717463 | 第十三届董事会第三十次会议决议公告 | 2026-04-29 | Chinese | ||
| 43717454 | 2026年一季度报告 | 2026-04-29 | Chinese | ||
| 43717444 | 2025年年度股东会决议公告 | 2026-04-28 | Chinese | ||
| 43717437 | 北京国枫(成都)律师事务所关于成都华神科技集团股份有限公司2025年年度股东会的法律意见书 | 2026-04-28 | Chinese | ||
| 43717425 | 关于召开2025年度网上业绩说明会的公告 | 2026-04-13 | Chinese | ||
| 43717417 | 关于拟续聘会计师事务所的公告 | 2026-03-30 | Chinese | ||
| 43717380 | 关于召开2025年年度股东会的通知 | 2026-03-30 | Chinese | ||
| 43717336 | 独立董事2025年度述职报告(毛道维) | 2026-03-30 | Chinese | ||
| 43717293 | 2025年度内部控制评价报告 | 2026-03-30 | Chinese | ||
| 43717284 | 关于公司董事、高级管理人员2025年度薪酬情况及2026年度薪酬方案的公告 | 2026-03-30 | Chinese | ||
| 43717252 | 关于独立董事独立性自查情况的专项报告 | 2026-03-30 | Chinese | ||
| 43717241 | 2025年度内部控制审计报告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Chengdu huasun technology group Inc., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53817/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53817 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53817 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53817 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53817}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Chengdu huasun technology group Inc., Ltd (id: 53817)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.